SUBSCRIBE
SUBSCRIBE
News   FDA

GlaxoSmithKline (JOBS) Wins U.S. Approval for Swine Flu Vaccine

November 11, 2009 | 
1 min read
Bookmark and Share

Reuters -- GlaxoSmithKline Plc (GSK.L) has won U.S. marketing approval to sell an unadjuvanted H1N1 swine vaccine, allowing it to ship relatively modest amounts of scarce vaccine to the United States next month.
FDA Approvals
GlaxoSmithKline
MORE ON THIS TOPIC
Crisis. Sanctions. Withdrawal of investment and capital. Stop participation. The collapse of the company, the split of business partners.
Autoimmune disease
Intercept Withdraws Embattled Liver Drug from US Market
September 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Unpacking the Latest MAHA Report, RFK’s Senate Appearance, FDA’s CRL Drop and More
September 10, 2025
 · 
1 min read
 · 
Jef Akst
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Complete response letters
FDA Turns Away Ultra-Rare Disease Therapy
September 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Modern collage with halftone hand holding pencil and drawing check mark. Confirmation. Concepts of agreement and choice
FDA
FDA Demurs on GLP-1 Compounding Fight, Debuts Consumer ‘Green List’ Instead
September 8, 2025
 · 
2 min read
 · 
Annalee Armstrong